CIC
Chilton Investment Company Portfolio holdings
AUM
$4.5B
This Quarter Return
+5.66%
1 Year Return
+26.04%
3 Year Return
+78.02%
5 Year Return
+132.72%
10 Year Return
+346.15%
AUM
$2.56B
AUM Growth
+$2.56B
(+4.6%)
Cap. Flow
-$36.5M
Cap. Flow
% of AUM
-1.42%
Top 10 Holdings %
Top 10 Hldgs %
39.76%
Holding
156
New
29
Increased
38
Reduced
52
Closed
22
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
$95.6M |
| 2 |
Citigroup
C
|
$77.6M |
| 3 |
Phillips 66
PSX
|
$74.9M |
| 4 |
Lockheed Martin
LMT
|
$72.8M |
| 5 |
PX
Praxair Inc
PX
|
$69M |
Top Sells
| 1 |
AutoNation
AN
|
$101M |
| 2 |
Thermo Fisher Scientific
TMO
|
$66.3M |
| 3 |
Brown-Forman Class B
BF.B
|
$62.5M |
| 4 |
Becton Dickinson
BDX
|
$62.1M |
| 5 |
Moody's
MCO
|
$53.3M |
Sector Composition
| 1 | Consumer Discretionary | 24.63% |
| 2 | Industrials | 17.61% |
| 3 | Materials | 14.42% |
| 4 | Financials | 13.71% |
| 5 | Healthcare | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Merck
MRK
$210B
| $647K | 0.03% |
10,187
+4,300
| +73% | +$273K |
|
102
iPath Select MLP ETN
ATMP
$504M
| $622K | 0.02% |
26,050
| – | – |
|
103
Intel
INTC
$105B
| $579K | 0.02% |
16,050
| – | – |
|
104
Automatic Data Processing
ADP
$121B
| $515K | 0.02% |
5,026
+134
| +3% | +$13.7K |
|
105
Colgate-Palmolive
CL
$67.7B
| $493K | 0.02% |
6,735
-195,220
| -97% | -$14.3M |
|
106
Badger Meter
BMI
$5.36B
| $467K | 0.02% |
+12,697
| New | +$467K |
|
107
Mueller Water Products
MWA
$4.07B
| $460K | 0.02% |
+38,894
| New | +$460K |
|
108
Ameriprise Financial
AMP
$47.8B
| $415K | 0.02% |
3,204
| – | – |
|
109
Mondelez International
MDLZ
$79.3B
| $408K | 0.02% |
9,466
-250
| -3% | -$10.8K |
|
110
Verizon
VZ
$184B
| $398K | 0.02% |
8,173
+380
| +5% | +$18.5K |
|
111
Intuitive Surgical
ISRG
$158B
| $383K | 0.01% |
500
| – | – |
|
112
Procter & Gamble
PG
$370B
| $362K | 0.01% |
4,033
-21,691
| -84% | -$1.95M |
|
113
Walmart
WMT
$793B
| $322K | 0.01% |
4,473
-25,721
| -85% | -$1.85M |
|
114
Estee Lauder
EL
$33.1B
| $314K | 0.01% |
+3,705
| New | +$314K |
|
115
Bristol-Myers Squibb
BMY
$96.7B
| $286K | 0.01% |
5,257
-1,562
| -23% | -$85K |
|
116
Chevron
CVX
$318B
| $282K | 0.01% |
2,622
| – | – |
|
117
AB InBev
BUD
$116B
| $275K | 0.01% |
2,506
-79,658
| -97% | -$8.74M |
|
118
CVS Health
CVS
$93B
| $266K | 0.01% |
3,391
-343
| -9% | -$26.9K |
|
119
Danaher
DHR
$143B
| $262K | 0.01% |
+3,067
| New | +$262K |
|
120
Brown & Brown
BRO
$31.4B
| $261K | 0.01% |
6,252
| – | – |
|
121
Schlumberger
SLB
$52.2B
| $244K | 0.01% |
3,126
| – | – |
|
122
Markel Group
MKL
$24.7B
| $241K | 0.01% |
+247
| New | +$241K |
|
123
Pfizer
PFE
$141B
| $232K | 0.01% |
6,772
+250
| +4% | +$8.58K |
|
124
Pinnacle West Capital
PNW
$10.6B
| $226K | 0.01% |
2,707
| – | – |
|
125
Abbott
ABT
$230B
| $213K | 0.01% |
4,795
-26,832
| -85% | -$1.19M |
|